Austin, MN4 Active Studies

Multiple Sclerosis Clinical Trials in Austin, MN

Find 4 actively recruiting multiple sclerosis clinical trials in Austin, MN. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
3,245
Enrolling

Recruiting Multiple Sclerosis Studies in Austin

About Multiple Sclerosis Clinical Trials in Austin

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 4 multiple sclerosis clinical trials recruiting participants in Austin, MN. These studies are seeking a combined 3,245 participants. Research is being sponsored by The University of Texas Health Science Center, Houston, GlaxoSmithKline, Francisco Gonzalez-Lima, PhD and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Austin — FAQ

Are there multiple sclerosis clinical trials in Austin?

Yes, there are 4 multiple sclerosis clinical trials currently recruiting in Austin, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Austin?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Austin research site will contact you about next steps.

Are clinical trials in Austin free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Austin studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 4 active trials in Austin are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov